Published: 2010-06-30

Articles

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (ACCORD lipid trial)

Commentary

Wioletta Dyrla

5-14

Requires Subscription PDF (Język Polski)

Fixed-dose combination with amlodypine/benazepril and chronic kidney disease – implications from the ACCOMPLISH trial

Review article

Agnieszka Wsół

15-19

Requires Subscription PDF (Język Polski)

The inhibition of renin-angiotensin-aldosterone system and myocardial infarction – what treatment according to EBM enables the best prevention?

Review article

Agnieszka Wsół, Marek Kuch

23-34

Requires Subscription PDF (Język Polski)

Metabolic aspects of beta-blockers action – (część II)

Review article

Andrzej Światowiec , Marek Kuch

35-40

Requires Subscription PDF (Język Polski)

Commentary on Reappraisal of European guidelines on hypertension management (part II)

Commentary

Jacek Lewandowski , Piotr Jędrusik

42-46

Requires Subscription PDF (Język Polski)

Dronedarone – a new and good amiodarone?

Review article

Agnieszka Liberska, Michał Mazurek, Zbigniew Kalarus

49-54

Requires Subscription PDF (Język Polski)

Prasugrel – what is known in 2010?

Review article

Maciej Janiszewski , Marek Chmielewski

57-61

Requires Subscription PDF (Język Polski)

Statistical significance and clinical import

Review article

Andrzej Cacko, Marcin Grabowski

64-68

Requires Subscription PDF (Język Polski)

ACC/AHA Guidelines Update for the Management of Patients With ST-Elevation Myocardial Infarction and Percutaneous Coronary Intervention (2009 STEMI and PCI Focused Updates). Do European guidelines need updating? – part II

Review article

Marek Chmielewski , Maciej Janiszewski

70-74

Requires Subscription PDF (Język Polski)

EBM – przegląd aktualnych publikacji

Katarzyna Sadkowska

76-88

Requires Subscription PDF (Język Polski)